In the MFC cell-derived subcutaneous xenograft model, GPX4-knockdown reduced tumor volume compared to scramble controls (P < 0.001), demonstrating potent suppression of gastric cancer progression (Figure 1B-D and Figure S1B). The gene discussed is GPX4; the disease is gastric cancer.